baber/WOPTO huggingface dataset:
Patent CA-2296306-A1 (CA)
Inventor: MAKA XAVIER
IPC: B32B27/32
Filed: 2000-01-20
Abstract: A multilayer stretch film comprises a first layer having cling properties and comprising an homogeneously-branched copolymer of ethylene and a C4-8 .alpha.-olefin, the copolymer having a density in the range 0.850 to 0.890 g/cm3, and a second layer having substantially no cling properties and comprising at least 80 wt.% of a low density polyethylene having a density in the range 0.915 to 0.940 g/cm3. Optionally, the film may comprise at least one core layer between the first and second layers. Films of this type are particularly suited to palletisation of loads.
Patent CA-2296606-A1 (CA)
Title: Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors
Inventor: GRECO FELICITA
IPC: C07D261/20
Filed: 1998-07-02
Abstract: A compound which is a condensed heterocycle of formula (I) wherein a, b and c are all single bonds; or a, b and c are all double bonds; or a is a double bond and b and c are single bonds; m is zero or an integer of 1 to 6; W is -CONH-, -SO2- or -CO-; X is O, S or NR2, in which R2 is hydrogen, C1-C6 alkyl, benzyl, pyridyl, tetrahydropyranyl or a phenyl ring unsubstituted or substituted by one or two substituents which are the same or different and are chosen independently from halogen, C1-C6 alkyl, C1-C6 alkoxy, nitro, amino, hydroxy, formylamino, C2-C6 alkanoylamino trifluoromethyl and C1-C6 alkoxycarbonyl; each of R and R1 is independently hydrogen, halogen, hydroxy, trifluoromethyl, nitro, amino, phenyl, benzyl, C1-C6 alkyl, C1-C6 alkoxy, C2-C6 alkanoylamino, formylamino or C1-C6 alkoxy-carbonyl; and Q is C1-C14 alkyl or a phenyl ring or an unsaturated pentatomic heteromonocyclic ring containing two or three heteroatoms chosen independently from oxygen, sulphur and nitrogen, wherein the phenyl ring and the heteromonocyclic ring are unsubstituted or substituted by one or two substituents which are the same or different and are chosen independently from halogen, hydroxy, trifluoromethyl, nitro, amino, phenyl, benzyl, C1-C6 alkyl, C1-C6 alkoxy, C2-C6 alkanoylamino, formylamino, and C1-C6 alkoxy-carbonyl, or a pharmaceutically acceptable salts thereof, is useful as a kynurenine-3-hydroxylase inhibitor.
Patent CA-2298271-A1 (CA)
Title: Non-encapsulation mobile ip
Inventor: CHEN XIAOBAO
IPC: H04L29/06
Filed: 2000-02-08
Abstract: There is provided a method of directing an internet protocol IP packet to a mobile node. The mobile node has a home address in a home network and is temporarily connectable in a foreign network having a foreign agent. The IP packet has a header portion including the destination address to which the IP packet is to be sent. The method comprises the steps of receiving, in the home network, the IP packet including a destination address corresponding to the home address of the mobile node; modifying the IP packet by: removing the home address of the mobile node from the header portion of the IP packet and replacing it with the foreign agent care-of address; appending a mobile node identifier to the IP packet; and transmitting the modified IP packet.
Patent CA-2301158-A1 (CA)
Title: Screening methods for compounds useful for modulating lipid metabolism in disease
Inventor: WINTHER MICHAEL D
IPC: C12N15/53
Filed: 2000-03-24
Abstract: The present invention relates to drug screening assays useful in the discovery of pharmaceutically active compounds for use in the treatment of diseases involving abnormal lipid metabolism including diabetic neuropathy, by utilizing fatty acid desaturase enzymes and the genes which encode them as targets for intervention. The drug screening method serves to identify nucleotides, proteins, compounds and/or other pharmacological agents which effectively modulate the activity of desaturase enzymes or regulate the level of expression of the desaturase genes. Cell-based and cell lysate assays are used to detect components that interact with the desaturase enzymes either as enhancers or inhibitors of desaturation, and hence, modify fatty acid profiles. In addition, cell-based and cell lysate assays are used to identify functional and regulatory elements controlling expression of the desaturase genes as well as to screen for components that modulate the transcriptional activity of the desaturase genes.
Patent CA-2302383-A1 (CA)
Title: A combination of a selective 5-ht1a antagonist and a selective h5-ht1b antagonist or partial agonist
Inventor: BERG STEFAN
IPC: A61K31/535
Filed: 1998-09-09
Abstract: The invention relates to a combination of a first component (a) which is a selective 5-HT1A receptor antagonist having formula (I), wherein R1 is n-propyl or cyclobutyl, R2 is isopropyl, tertiary butyl, cyclobutyl, cyclopentyl or cyclohexyl, R3 is hydrogen and R4 is hydrogen or methyl and being in the (R)-enantiomer form, with a second component (b) which is a selective h5-HT1B  antagonist or partial agonist having formula (II), wherein X is CH2, O, Y is CONH, NHCO, R1 is H, C1-C6 alkyl, C3-C6 cycloalkyl, R2 is H, C1-C6 alkyl, C1-C6 alkoxy, halogen, R3 is (1), (2), (3), (4), (5); R4 and R5 independently are H or C1-C4 alkyl as racemate R-enantiomer or S-enantiomer, and said components (a) and (b) being in the form of free bases, solvates or pharmaceutically acceptable salts thereof, the preparation thereof, pharmaceutical formulations containing said combination, use of and method of treatment of affective disorders such as depression, anxiety and OCD with said combination as well as a kit containing said combination.
Patent CA-2303531-A1 (CA)
Title: Electrical power distribution switch
Inventor: TYRJAN WALTER A
IPC: H01H33/02
Filed: 2000-03-31
Abstract: An electrical power distribution switch includes an operating member that carries a first plurality of spaced switch contacts and a support arrangement for pivotally supporting the operating member. One of the ends of the operating member includes a circumferential bearing surface. The support arrangement cooperates with the circumferential bearing surface. In a preferred arrangement, electrical connections to the spaced switch contacts carried by the operating member are oriented to provide clearance to cable terminations while also simplifying the electrical connection components.
Patent CA-2304842-A1 (CA)
Title: Cushioned rubber floor mat article comprising at least one integrated rubber protrusion and at least two layers of rubber
Inventor: KERR ROBERT C
IPC: B29C44/06
Filed: 2000-04-11
Abstract: This invention relates to a cushioned dust control mat article wherein the mat comprises at least two distinct layers of rubber, one comprising foam rubber, the other comprising solid rubber. The solid rubber layer is present over the foam rubber layer on the side of the mat in which at least one integrated rubber protrusion is present to provide cushioning characteristics. The solid rubber layer acts as a cap or barrier for the foam rubber layer, particularly over the integrated protrusion or protrusions, in order to provide a mat which is resilient, will not easily degrade in its modulus strength after appreciable use and/or washing within industrial cleaning processes, and will not exhibit appreciable cracking or breaking, particularly within the integrated protrusion(s), after standard use for pedestrian traffic. A method of producing such an inventive cushioned floor mat article is also provided.
Patent CA-2306302-A1 (CA)
Inventor: ROSENBERGER BERNHARD
IPC: H01R13/646
Filed: 2000-04-20
Abstract: A coaxial connector comprises am outer conductor having an inner diameter D, an inner conductor coaxial with the outer conductor and having an outer diameter d, and an insulating structure having plural radii between the conductors. The diameters are selected in such a manner that the connector has a predetermined characteristic impedance (see figure I). The connector has a first cable side for connection to a coaxial cable and a second connection side for connection to a corresponding coaxial connector. The insulating structure is one piece, including a disk and tube, together having a bore with a diameter less than d. The inner conductor is inserted into the bore of the tube that is mounted in proximity to the second end. The disk periphery is fixedly mounted against the inner wall of the outer conductor. The portion of the inner conductor in the bore and the bore have a smaller diameter than d to compensate for the dielectric properties of the insulating structure in such manner that the connector has the predetermined characteristic impedance Z o where the insulating structure is located. The structure radii are selected as a function of the structure dielectric constant .epsilon. in such manner that the predetermined characteristic impedance Z o wave equation is attained.
Patent CA-2308896-A1 (CA)
Title: Phosphonium salts
Inventor: ROBERTSON ALLAN JAMES
IPC: C07C45/46
Filed: 2000-05-18
Abstract: The invention provides a phosphonium salt of formula I      R1R2R3R4P+ X-wherein R1, R2, R3, and R4 are Cl-20 hYdrocarbyl groups and X is an anion, except halide, provided that (i) Rl, R2, R3 and R4 are not all the same; and (ii) not more than two of R1, R2, R3 and R4 are aryl. Such phosphonium salts may be useful as catalysts, solvents, and electrolytes.
Patent CA-2310265-A1 (CA)
Inventor: SAKIURA TOSHIYUKI
IPC: A01K61/00
Filed: 2000-05-30
Abstract: A system for feeding fries with feeding water treated with a photocatalyst without administering medicines, such as vaccines, etc. to drastically improving a death rate of the fries. In the fry death rate improving system according to the present invention a photocatalysis body is contacted directly to water for fries to be fed with to feed the fires.  A photocatalysis device of the fry death rate improving system according to the present invention comprises a photocatalysis tank, a light source for radiating a photocatalyst, an inlet for feeding water provided in the photocatalysis tank, an outlet for the photocatalyzed feeding water and a preserve tank disposed below the outlet. A plurality of partition plates with a fabric adhered to having the photocatalysis body applied to by flame spray coating are juxtaposed with each other in the photocatalysis tank in a manner which contacts the feeding water, causing turbulent flows in the feeding water.
Patent CA-2311550-A1 (CA)
Title: Method and equipment for controlling properties of paper
Inventor: TIAN LIN
IPC: D21F7/06
Filed: 1998-11-23
Abstract: The invention relates to a method and equipment for controlling properties of paper, in which method the effect of the flow of retention agent (F ra) and the stock flow (F ts) on the basis weight of the paper (BW) is modelled. The fulfilled modelling is used to adjust the basis weight of the paper (BW) by controlling simultaneously the flow of retention agent (F ra) and the stock flow (F ts).
Patent CA-2312990-A1 (CA)
Inventor: POWERS GERALD L
IPC: A61K31/4965
Filed: 1998-12-01
Abstract: Novel salts of the antidiabetic agent metformin are provided which are metformin salts of dibasic acids (2:1 molar ratio), preferably metformin (2:1) fumarate and metformin (2:1) succinate, which may be employed alone or in combination with another antihyperglycemic agent such as glyburide, for treating diabetes. A method for treating diabetes employing the novel metformin salt by itself or in combination with another antidiabetic agent is also provided.
Patent CA-2314148-A1 (CA)
Title: Pharmaceutical formulations and processes for their preparation
Inventor: BADAWY SHERIF I
IPC: A61K9/48
Filed: 1999-01-14
Abstract: Provided is a pharmaceutical composition comprising a tablet or capsule containing a pharmacologically effective amount of a pharmaceutical compound, or a pharmaceutically acceptable salt thereof, having an amidine-based group and an optional ester group, a pharmaceutically acceptable solid carrier, and a pharmaceutically acceptable acid in an amount to modify the pH of the composition to substantially that of the compound at pH of maximum stability. Such a composition is prepared by adding water during formulation manufacture and contacting the compound during formulation manufacture with a pharmaceutically acceptable acid having a pH in a saturated aqueous solution substantially that of the compound at pH of maximum stability.
Patent CA-2316802-A1 (CA)
Inventor: ERLANDER MARK G
IPC: C12Q1/6809
Filed: 1999-04-30
Abstract: The present invention provides a new method for producing gene expression profiles from a selected set of cells. This method combines and utilizes known methods in a novel way to produce the gene expression profiles. These gene expression profiles are useful for the identification of differentially expressed genes in specific cells.
Patent CA-2320139-A1 (CA)
Inventor: BENJAMIN DENNIS ANDREW
IPC: H04M3/42
Filed: 1999-02-05
Abstract: L'invention concerne un procédé d'obtention d'un document qui consiste à recevoir un appel téléphonique d'un client vers un numéro de bureau central, à répondre à l'appel, à demander le numéro d'identification et à transmettre les données client représentant le document identifié par ledit numéro d'identification. Ce numéro d'identification est un numéro de téléphone d'une société associée au document.
Patent CA-2321105-A1 (CA)
Title: Proteine de la famille des recepteurs a chaine courte humains du tnf
Inventor: TANG Y TOM
IPC: C12N15/09
Filed: 1999-02-05
Abstract: L'invention porte sur une protéine de la famille des récepteurs à chaîne courte humains du TNF (SCTR) et sur des polynucléotides identifiant le SCTR et codant pour lui. L'invention porte également sur des vecteurs d'expression, des cellules hôtes, des agonistes et des antagonistes ainsi que sur des méthodes de traitement ou prévention de troubles associés à l'expression du SCTR.
Patent CA-2323073-A1 (CA)
Inventor: MOSCA JOSEPH D
IPC: A61K35/12
Filed: 1999-03-12
Abstract: Methods and devices using non-autologous mesenchymal stem cells comprising treating a recipient in need thereof with an effective amount of nonautologous mesenchymal stem cells, including methods and preparations for treating and regenerating connective tissue and enhancing bone marrow engraftment in an individual; and for using genetically engineered allogeneic human mesenchymal stem cells that carry within them genes of interest particularly for the expression of physiologically or pharmacologically active proteins in gene therapy for correction of genetic disorders or "rebuilding" proteins important in tissue repair.
Patent CA-2324785-A1 (CA)
Inventor: LECLERC SIMON
IPC: A47B57/40
Filed: 2000-10-31
Abstract: A storage rack formed of a plurality of shelves and posts is equipped with hooks allowing the shelves to be removably mounted to the posts; each post displays a series of vertically spaced slots; each shelf displays a horizontal storage top face and narrow vertical side faces.      Each corner of the shelf displays, in a side face, a notch defining a horizontal edge and a vertical edge. Each hook has a first portion adapted to be inserted in a post slot allowing the hook to be mounted to the post and a second portion extending outside the slot and shaped to receive the horizontal edge of the shelf notch with the one side face of the shelf being wedged between the post and the hook. The vertical edge of the notch, when contacting the second portion of the hook limits the horizontal movement of the shelf relative to the post.
Patent CA-2326651-A1 (CA)
Inventor: DEGEN ALEXANDER
IPC: E02D13/06
Filed: 1999-03-30
Abstract: Device for inserting foreign matters into the soil and/or for compacting the  soil, comprising a countersinking unit (22) with a depth vibrator, that is coupled to an articulated arm, in addition to a control device through which  the articulated arms (2, 3, 4) can be controlled in such a way that the countersinking unit can be displaced linearly in a predetermined direction along its longitudinal extension.
Patent CA-2328242-A1 (CA)
Inventor: DURGIN RUSS
IPC: A61B18/14
Filed: 1999-03-01
Abstract: la présente invention concerne un ensemble de cathéter intégré utilisé dans le cadre de divers traitements endoscopiques in situ. L'ensemble comprend un cathéter (12) avec lumière pour fluide d'irrigation, une partie distale à pointe d'électrode (20) à action hémostatique et un fil de coupe (23) pour l'incision ou l'ablation de tissus. Le fil de coupe traverse une gaine étanche (21). Grâce à un manipulateur (24), le médecin peut déplacer le fil de coupe entre des positions sorti et rentré. Le fil de coupe et l'électrode sont électriquement isolés. La présente invention permet d'effectuer des opérations d'incision ou d'ablation de tissus par électrochirurgie, d'irriguer des tissus et de procéder à une cautérisation ou à une coagulation sans devoir retirer l'appareil de la gaine de l'endoscope.
Patent CA-2329065-A1 (CA)
Inventor: SJOGREN ERIC BRIAN
IPC: A61K31/54
Filed: 1999-04-28
Abstract: The present invention relates to certain pyrazole derivatives of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Patent CA-2329382-A1 (CA)
Inventor: FIELDING ALAN
IPC: G02B6/34
Filed: 2000-12-21
Abstract: It is found that the use of a multimode interference (MMI) section (22, 33, 36) to flatten the pass-bands of an arrayed waveguide grating (AWG) multiplexer/demultiplexer or comb filter device introduces undesirable wavelength dispersion into those pass-bands if that MMI section mixes modes of more than two different orders, and if the grating of that device is a 'uniform' grating whose waveguides are equally (minimally) attenuating, and in which the optical path length difference between each adjacent pair of waveguides 40 of the array is the same. This dispersion can be substantially compensated by appropriate 'tailoring' of the grating to remove such uniformity.
Patent CA-2330810-A1 (CA)
Title: Air conditioning method and device
Inventor: RIBO ROBERT
IPC: F24F11/76
Filed: 1999-05-04
Abstract: The invention concerns a method and a device for variable flow heating for controlling ventilating fresh air room by room in a building. The invention is characterised in that said method provides sequential control of the air using a central management unit (48) programmed to be configured, either in a mode controlling the temperature levels in the main rooms (8) wherein it maintains the set temperature in said rooms and senses the possible complete closure of the (or all) the air outlets (5) supplying said main rooms, or at least if one of the main rooms is no longer supplied, in a mode controlling fresh air wherein it controls the opening of the air outlet(s) of each room not initially supplied during a time interval for making up for the lack of fresh air supply, and by closing the air outlets in all the other rooms during the same interval.
Patent CA-2331254-A1 (CA)
Title: Methods for the detection of nucleic acids
Inventor: LAPIDUS STANLEY N
IPC: C12Q1/6827
Filed: 1999-06-16
Abstract: Methods are provided for identifying nucleic acids. Methods of the invention  are useful for identifying and analyzing nucleic acids, especially variants of single nucleotide polymorphisms, that are indicative of disease or the predisposition for disease.
Patent CA-2331382-A1 (CA)
Title: Interaction de p27(kip1) avec fkbp-12
Inventor: NANDABALAN KRISHNAN
IPC: A61P37/02
Filed: 1999-06-18
Abstract: La présente invention concerne une interaction entre p27(Kip1) et FKBP-12 et la formation d'un complexe entre p27(Kip1) et FKBP-12, ou entre des dérivés, fragments, analogues et homologues de ces protéines, lesquelles ont été identifiées à l'aide d'un système modifié, perfectionné de dosage de deux hybrides à partir de levure. L'invention concerne également des méthodologies de criblage des complexes ci-dessus mentionnés, servant au traitement et/ou à la prévention efficaces de divers troubles et maladies, notamment des syndromes hyperprolifératifs, à savoir, sans y être limité, le cancer, les maladies neurodégénératives et auto-immunes, et analogue.
Patent CA-2332692-A1 (CA)
Title: Telephone line powered central office drop and reconnect method and apparatus
Inventor: FLEURY FARON
IPC: H04M1/2749
Filed: 2001-01-29
Abstract: An automatic dialer and a method for its use with PSTN telephone lines. A timer within the automatic dialer initiates a programmable countdown when the PSTN line goes off-hook. Then, when the countdown expires, a signal is generated which alerts the CPU to the need for a shutdown. The shutdown sequence begins by preparing an auxiliary power supply that can supply power to the CPU while the telephone line current is unavailable. After the preparation, the CPU enters a low power mode which effectively shuts down the CPU but does not lose the CPU's internal data. The PSTN line is then caused to go on-hook by the dialer for a length of time sufficient to terminate the line. After this length of time, a signal is generated which causes the CPU to exit its low power mode and causes the dialer to acquire a new PSTN line. The new PSTN line then supplies power to the CPU and the CPU then resumes its previous function using its internal data. The CPU can thus resume its routing or control access sequence determination where it left off without losing any data.      The call can therefore now be initiated using the new PSTN line.
Patent CA-2336348-A1 (CA)
Title: Catalyseurs de sulfuryle et leur procede d'utilisation
Inventor: NAGY SANDOR
IPC: C08F10/02
Filed: 1999-08-05
Abstract: L'invention porte sur un nouveau catalyseur métallocène utilisé dans la polymérisation de (co)polymères oléfiniques et ayant la formule générale: R-SO¿2?-L-M-(X)mTn dans laquelle M est un métal sélectionné dans les groupes 3 à 10; T est un ligand ancillaire anionique stable à la polymérisation; m+n est la valence de M moins 1; R est un groupe C¿1?-C¿20? alkyle, un noyau C¿6?-C¿20? aryle ou un groupe C¿6?-C¿20? alcaryle ou aralkyle, éventuellement substitué par un halogène ou un groupe alcoxy possédant jusqu'à 10 atomes de carbone; X est un halogène, un alcoxy C¿1? à C¿20?, un siloxy C¿1? à C¿20?, N(R)¿2?, un groupe hydrocarbyle contenant jusqu'à environ 12 atomes de carbone, hydrogène ou un autre ligand anionique univalent ou des mélanges de ceux-ci; L représente T tel que défini ci-dessus à condition que l'un des sites disponibles pour la substitution soit le site de fixation du groupe sulfuryle; et L et T peuvent être pontés.
Patent CA-2339051-A1 (CA)
Title: Ketolide antibiotics
Inventor: ZHAO HONGJUAN
IPC: A61P31/04
Filed: 2001-03-02
Abstract: Disclosed are compounds of the formula 1 (see formula 1) and to pharmaceutically acceptable salts, prodrugs, and solvates thereof wherein X1 is O, -CR4R5 or -NR4; R1 is H or optionally substituted alkyl; R2 is -(CR4R5)n-heterocycle or -(CR4R5)n aryl where n is 0 to 6; R4 and R5 are each H, alkyl etc.; R8 is H, alkylcarbonyl benzyl, benzyloxycarbonyl or trialkylsilyl; R9 is H, alkyl, alkenyl or alkynyl; and R10 is Cl, Br, I, F or CN. The compounds of formula 1 are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections.
Patent CA-2340262-A1 (CA)
Inventor: ALBRECHT WOLFGANG
IPC: H01H/
Filed: 1999-06-04
Abstract: The invention relates to a step switch with a selector for continuous switching between different winding tappings of a tapped transformer. The entire selector is configured as a separate component group and housed in a separate housing made of an insulating material. The fixed selector contacts are configured in a circular manner and arranged around a switch stick in different planes in the interior of the insulating cylinder. They are switched by selector contact bridges which have radially elastic contact elements and are fixed to the switch stick.